Related Experiment Video
Updated: Apr 20, 2026

Author Spotlight: Advancements in Understanding and Combatting Shigella Infections
Published on: February 9, 2024
Molecular characterization of Shigella spp. from patients in Gabon 2011-2013
Frieder Schaumburg1, Abraham S Alabi2, Harry Kaba2
1Institute of Medical Microbiology, University Hospital Münster, 48149 Münster, Germany Centre de Recherches Médicales de Lambaréné (CERMEL), PB 118 Lambaréné, Gabon frieder.schaumburg@ukmuenster.de.
Background:
Shigella spp. dysentery is widespread in developing countries; the incidence is particularly high in children between 1-2 years of age. In sub-Saharan Africa, there is a paucity of epidemiological data on Shigella spp., with possible negative consequences for recognition and correct treatment choice for this life-threatening bacterial infection. We therefore characterized Shigella spp. isolates from Gabon.
Methods:
The antimicrobial resistance, virulence factors, genotypes and mobile genetic elements of Shigella isolates (29 S. flexneri; 5 S. boydii; 3 S. sonnei) from a retrospective strain collection were analyzed.
Results:
High resistance rates were found for gentamicin and tetracycline (100%, 37/37), cotrimoxazole (92%, 34/37) and ampicillin (84%, 31/37). All isolate harbored ial and ipaH; no isolate produced Shiga toxins (stx1/2); enterotoxins (set1A/B) were only found in S. flexneri (n=19). Multilocus sequence types (MLST) clustered with global clones. A high prevalence of atypical class 1 integrons harboring blaOXA30 and aadA1 were detected in S. flexneri, while all S. sonnei carried class 2 integrons.
Conclusions:
There is a strong link of Gabonese Shigella spp. isolates with pandemic lineages as they cluster with major global clones and frequently carry atypical class 1 integrons which are frequently reported in Shigella spp. from Asia.
Related Concept Videos
Bacterial Gastroenteritis
Modern Molecular Taxonomy

